OPTEL is the only company with the ability to provide true end-to-end traceability, collecting, connecting and leveraging granular data at every step of the supply chain, from raw materials to the consumer and beyond.
With the help of cutting-edge technologies such as artificial intelligence, the Internet of Things, blockchain and cloud computing, OPTEL offers unparalleled supply chain visibility, giving any company—in any industry—the tools to make actionable, real-time decisions based on data you can trust.
Through systematic product identification, tracking, data acquisition and connectivity, OPTEL’s innovative traceability solutions allow you to verify and track the history, location and even the state or status of individual products, regardless of where they are in the supply chain.
As the key to product life-cycle analysis, end-to-end traceability improves data collection to provide more accurate parameters for day-to-day operations and advanced planning solutions … making everyone’s business run better.
Serving the pharma industry for nearly 30 years, OPTEL offers proven custom and preconfigured traceability solutions to help achieve serialization compliance and so much more.
OPTEL offers turnkey vision inspection and traceability solutions for medical devices, designed to meet current and future needs.
Achieve unprecedented transparency, performance, and manufacturing efficiency thanks to the Intelligent Supply Chain enabled by OPTEL’s end-to-end traceability systems, leveraging blockchain technologies.
OPTEL’s GeoTraceability platform enables mining organizations to make informed, actionable decisions, better engage with their employees and communities and more efficiently manage resources.
OPTEL is the leading global provider of traceability systems, and its mission is to use its innovative technologies to create a better world through the Intelligent Supply Chain.TM
OPTEL is the only company with the ability to offer true end-to-end traceability – from extraction of raw materials to the consumer – allowing diverse industries to benefit from actionable, real-time data to ensure the quality and integrity of consumer products, help stop counterfeiting and reduce waste.
Founded in 1989, OPTEL is a Certified B Corporation based in Canada, with facilities in the United States, Ireland, India and Brazil, as well as employees worldwide.
OPTEL has been chosen to participate in the U.S. Food and Drug Administration’s Drug Supply Chain Security Act (DSCSA) Pilot Project Program to help identify and trace prescription drugs as they are distributed within the United States.
Nelipak and OPTEL have entered into an agreement of intent to explore commercial opportunities for a new seal inspection technology for medical devices. The novel concept for vacuum-formed trays will be demonstrated at MedtecLIVE 2019.
Real Leaders, Big Path Capital, and B Lab have teamed up to assess and rank the “100 Top Impact Companies” of 2019 and are proud to announce that OPTEL ranked 6 out of 99 inaugurals winners!